Drugs and Biologicals - Coverage for Label and Off-Label Uses
L25820
R2 Effective Date: March 1, 2008
Source of Revision - Internal: The following articles have been added:
Alteplase (A46754),
Fulvestrant (A46755),
Infliximab (e.g., Remicade) (A46764),
Irinotecan Hydrochloride (e.g., Camptosar) (A46757),
Oxaliplatin (e.g., Eloxatin) (A46756),
Paclitaxel (e.g., Taxol) (A46758),
Pamidronate Disodium for Injection (e.g., Aredia) (A46738),
Tositumomab and Iodine I 131 Tositumomab (e.g., Bexxar) (A46759) and
Vinorelbine Tartrate (e.g., Navelbine) (A46778).
Bill type 11X has been added and several minor changes were made to reflect the National Government Services current policy formats. No comment and notice periods required and none given.
|